Hyperplasia of the thyroid gland;Hyperplasien der schilddrüse

Pathologe

Volumn 24, Issue 5, 2003, Pages 348-356

  Sheu, S Y ^b   Gorges R ^b   Schmid, K W ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b NONE

Author keywords

C cell hyperplasia; Goitre; Graves' disease

Indexed keywords

CALCITONIN;

CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; GOITER; GRAVES DISEASE; REVIEW; THYROID ADENOMA; THYROID HYPERPLASIA; THYROID MEDULLARY CARCINOMA; THYROID PARAFOLLICULAR CELL;

HUMANS; HYPERPLASIA; HYPERTHYROIDISM; THYROID DISEASES; THYROID GLAND; THYROID NEOPLASMS;

EID: 0141459690     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00292-003-0627-8     Document Type: Review

References (17)

1. Chazenbalk GD, Pichurin P, Chen CR et al. (2002) Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor. J Clin Invest 110: 209-217
2. Collins J, Gough S (2002) Autoimmunity in thyroid disease. Eur J Nucl Med Mol Imaging 29 Suppl 2: S417-S424
3. Ghossein RA, Rosal J, Heffess C (1997) Dyshormonogenetic Goiter: A Clinicopathologic Study of 56 Cases. Endocr Pathol 8: 283-292
4. Hinze R, Gimm O, Brauckhoff M et al. (2001) "Physiologische" und "neoplastische" C-Zell-Hyperplasien der Schilddrüse. Morphologisch und biologisch distinkte Entitäten? Pathologe 22: 259-265
5. Kaserer K, Scheuba C, Neuhold N et al. (1998) C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin. Am J Surg Pathol 22: 722-728
6. Lever EG, Medeiros-Neto GA, DeGroot LJ (1983) Inherited disorders of thyroid metabolism. Endocr Rev 4: 213-239
7. Lloyd RV, Douglas BR, Young WF (2002) Thyroid gland. Endocrine diseases. Atlas of nontumor pathology, 1st series, fascicle 1. ARP and AFIP, Washington/DC
8. Papotti M, Fara E, Ardeleanu C, Bussolati G (1994) Occurence and significance of vascular invasion in multinodular adenomatous goiter. Endocr Pathol 5: 35-39
9. Perry A, Molberg K, Albores-Saavedra J (1996) Physiologic vs. neoplastic C-cell hyperplasia of the thyroid: separation of distinct histologic and biologic entities. Cancer 77: 750-756
10. Quadbeck B, Eckstein AK, Tews S et al. (2002) Maturation of thyroidal dendritic cells in Graves' disease. Scand J Immunol 55: 612-620
11. Rosai J, Carcangiu ML, DeLellis RA (1992) Tumors of the thyroid gland. Atlas of tumor pathology. AFIP. Washington/DC
12. Schmid KW, Ensinger C (1998) Possible relationship between the tall cell variant of papillary thyroid carcinoma and Graves' disease. J Pathol 184: 31A
13. Schmid KW, Schröder S, Schäffer R, Hinze R, Stömmer P (2003) Anwendungsleitlinien zur pathologischen Diagnostik des Schilddrüsenkarzinoms. Qualitäts-Kommission der Deutschen Gesellschaft für Pathologie und des Berufsverbandes Deutscher Pathologen. (In Vorbereitung)
14. Shapiro SJ, Friedman NB, Perzik SL, Catz B (1970) Incidence of thyroid carcinoma in Graves' disease. Cancer 26: 1261-1270
15. Tunbridge WM, Evered DC, Hall R et al. (1977) The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 7: 481-493
16. Weetman AP (2001) Determinants of autoimmune thyroid disease. Nat Immunol 2: 769-770
17. Wolfe HJ, Delellis RA (1981) Familial medullary thyroid carcinoma and C cell hyperplasia. Clin Endocrinol Metab 10: 3S1-36S